iShares Trust - iShares Biotechnology ETF
GB ˙ LSE ˙ US4642875565
131,05 $ ↓ -0,77 (-0,58%)
2023-12-18
AKTIENPREIS
SecurityGB:0JGB / iShares Trust - iShares Biotechnology ETF
InstitutionUs Bancorp \de\
Latest Disclosed Ownership16,249 shares
Latest Disclosed Value $ 2,743,650
Us Bancorp \de\ reports 12.40% increase in ownership of 0JGB / iShares Trust - iShares Biotechnology ETF

On May 14, 2026 - Us Bancorp \de\ filed a 13F-HR form disclosing ownership of 16,249 shares of iShares Trust - iShares Biotechnology ETF (GB:0JGB) valued at $2,743,650 USD as of March 31, 2026. The entity filed a previous 13F-HR on January 30, 2026 disclosing 14,457 shares of iShares Trust - iShares Biotechnology ETF. This represents a change in shares of 12.40% during the quarter. The current value of the position is $2,129,431 USD.

Institutional Ownership: 13F and NPORT Filings

The Security and Class in the table below are shown exactly as filed by the investor. We do our best to track continuity of investments through acquisitions, and this will be reflected in the table as changes in names. In addition to descriptive data, performance of the investment is shown over time. To calculate quarterly performance, we first calculate cost basis of the shares purchased during the quarter, then use that to calculate gross profit. Quarterly return is Gross Profit / Starting Portfolio value.

Note that cost basis is calculated and stored in thousands, so small quarterly changes in shares frequently result in a cost basis of zero.

Upgrade to unlock premium data and export to Excel .

Disclosed Equity Positions (from 13F/NPORT Filings)
File
Date
Effective
Date
Form Security Class ID Avg Price
Paid (Est)
Reported
Shares
ΔShares ΔShares
(%)
Reported
Value
(x1000)
ΔValue
(%)
Alloc
(%)
ΔAlloc ΔAlloc (%) Cost Basis
(x1000)
Unrealized
Gain/Loss
(x1000)
2026-05-14 2026-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 16,249 1,792 12.40 2,744 12.46 0.0010
2026-01-30 2025-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,457 -725 -4.78 2,440 11.32 0.0029
2025-11-12 2025-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,182 112 0.74 2,192 14.95 0.0026
2025-07-24 2025-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 15,070 -136 -0.89 1,907 -1.95 0.0024
2025-05-08 2025-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,206 1,604 11.79 1,945 8.12 0.0026
2025-02-05 2024-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 13,602 -426 -3.04 1,798 -11.95 0.0024
2024-10-28 2024-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 14,028 378 2.77 2,042 9.02 0.0026
2024-08-07 2024-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 13,650 -1,056 -7.18 1,874 -7.14 0.0026
2024-05-08 2024-03-31 13F ISHARES TR ISHARES BIOTECH 464287556 14,706 -543 -3.56 2,018 -2.61 0.0028
2024-02-09 2023-12-31 13F ISHARES TR ISHARES BIOTECH 464287556 15,249 -1,238 -7.51 2,072 2.73 0.0031
2023-11-03 2023-09-30 13F ISHARES TR ISHARES BIOTECH 464287556 16,487 -951 -5.45 2,016 -8.90 0.0033
2023-08-10 2023-06-30 13F ISHARES TR ISHARES BIOTECH 464287556 17,438 -412 -2.31 2,214 -3.99 0.0036
2023-05-09 2023-03-31 13F ISHARES BIOTECHNOLOGY ETF OTHER 464287556 17,850 -4,416 -19.83 2,306 -21.14 0.0039
2023-02-13 2022-12-31 13F ISHARES BIOTECHNOLOGY ETF OTHER 464287556 22,266 8,104 57.22 2,923 76.51 0.0052
2022-10-27 2022-09-30 13F ISHARES BIOTECHNOLOGY ETF OTHER 464287556 14,162 -5,172 -26.75 1,656 -27.21 0.0034
2022-08-01 2022-06-30 13F ISHARES BIOTECHNOLOGY ETF OTHER 464287556 19,334 -13,009 -40.22 2,275 -46.01 0.0044
2022-05-11 2022-03-31 13F ISHARES BIOTECHNOLOGY ETF OTHER 464287556 32,343 11,737 56.96 4,214 33.99 0.0070
2022-02-11 2021-12-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 20,606 314 1.55 3,145 -4.15 0.0050
2021-11-10 2021-09-30 13F ISHARES BIOTECHNOLOGY ETF OTHER 464287556 20,292 -84 -0.41 3,281 -1.59 0.0062
2021-08-05 2021-06-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 20,376 -119 -0.58 3,334 8.04 0.0062
2021-04-28 2021-03-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 20,495 -254 -1.22 3,086 -1.81 0.0062
2021-02-04 2020-12-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 20,749 1,413 7.31 3,143 20.05 0.0068
2020-11-10 2020-09-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 19,336 -500 -2.52 2,618 -3.43 0.0064
2020-08-07 2020-06-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 19,836 21 0.11 2,711 26.98 0.0071
2020-05-13 2020-03-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 19,815 1,589 8.72 2,135 -2.78 0.0067
2020-02-04 2019-12-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 18,226 1,696 10.26 2,196 33.58 0.0056
2019-11-08 2019-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 16,530 -415 -2.45 1,644 -11.09 0.0045
2019-08-13 2019-06-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 16,945 -13,024 -43.46 1,849 -44.82 0.0052
2019-05-08 2019-03-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 29,969 -3,418 -10.24 3,351 4.07 0.0097
2019-02-13 2018-12-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 33,387 -630 -1.85 3,220 -22.37 0.0104
2018-10-31 2018-09-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 34,017 1,422 4.36 4,148 15.87 0.0120
2018-08-08 2018-06-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 32,595 2,032 6.65 3,580 9.75 0.0110
2018-05-08 2018-03-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 30,563 2,747 9.88 3,262 9.83 0.0100
2018-02-02 2017-12-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 27,816 19,176 221.94 2,970 3.09 0.0091
2017-11-13 2017-09-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 8,640 156 1.84 2,881 9.50 0.0092
2017-07-19 2017-06-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 8,484 307 3.75 2,631 9.72 0.0088
2017-05-03 2017-03-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 8,177 -1,003 -10.93 2,398 -1.56 0.0082
2017-02-08 2016-12-31 13F ISHARES NASDAQ BIOTECH OTHER 464287556 9,180 2,139 30.38 2,436 19.59 0.0088
2016-11-04 2016-09-30 13F ISHARES NASDAQ BIOTECH OTHER 464287556 7,041 1,731 32.60 2,037 49.01 0.0076
2016-08-10 2016-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,310 -236 -4.26 1,367 -5.53 0.0052
2016-05-13 2016-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,546 3 0.05 1,447 -22.87 0.0057
2016-02-10 2015-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,543 -64 -1.14 1,876 10.29 0.0075
2015-11-16 2015-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,607 -1,542 -21.57 1,701 -35.49 0.0071
2015-08-10 2015-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 7,149 559 8.48 2,637 16.53 0.0102
2015-05-08 2015-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 6,590 1,083 19.67 2,263 35.43 0.0087
2015-02-13 2014-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,507 0 0.00 1,671 10.88 0.0065
2014-11-14 2014-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,507 170 3.19 1,507 9.84 0.0061
2014-08-14 2014-06-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 5,337 433 8.83 1,372 18.38 0.0055
2014-05-14 2014-03-31 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 4,904 1,961 66.63 1,159 73.50 0.0047
2014-02-13 2013-12-31 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 2,943 811 38.04 668 49.44 0.0027
2013-11-07 2013-09-30 13F ISHARES NASDAQ BIOTECHNOLOGY E OTHER 464287556 2,132 104 5.13 447 26.63 0.0020
2013-08-09 2013-06-30 13F I SHARES NASDAQ BIOTECH INDEX OTHER 464287556 2,028 2,028 353 0.0016
Legend
Shares
The total number of shares held by the institution at the end of the reporting period (the effective date). This is provided in the filing.
Value
The total value of the shares as of the effective date. This is provided in the filing.
Avg. Share Price
The weighted average share price of the shares held by the institution. We use FIFO accounting to determine this price
Class
This is the security class as indicated by the filer. There are a variety of values for this field. Common values include "EC" = equity common, "EP" - equity preferred
Allocation (%)
The percent of the institution's portfolio that this position represents. This is provided in NPORT filings. For 13F filings, we calculate it.
Change in Allocation
The change in allocation from the prior reporting period. This is calculated as current allocation - prior allocation.
Change in Allocation (%)
The percent change in allocation from the prior reporting period. This is calculated as (current allocation - prior allocation) / prior allocation.
Cost Basis
The total cost of the shares held. This is calculated as reported shares * avg. share price
Unrealized Gain/Loss
This is the market value of the position as of the effective date minus the cost basis.